Article
Orlando, FL-A study from the University of Toronto has created a credo for urology patients who purchase products from the $27 billion nutritional supplement industry: "Caveat emptor"-let the buyer beware.
Study underway to assess 3-fraction SBRT regimen in prostate cancer
Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management
“Go big or go small”: Current and emerging tools in kidney stone management
Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
FDA clears stapler for use with da Vinci SP surgical system
Polygenic risk score may identify more clinically significant PCa than PSA, MRI
Coding Q&A: How to bill for second-generation stone device
Minimal approach to WVTT linked to favorable post-operative outcomes